Morepen Laboratories Limited

Web: morepen.com NSE: MOREPENLAB BSE: 500288 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

113 4(-4%)

Near 52W High of 119

Volume

2c as on 23, Jun

Open

High

Low

117

VWAP

52 Week High

119

52 Week Low

Viand Research Rating

Quality Score

11/100

Growth Score

23/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

6,191

No. of Shares

54.8

P/E

30.08

P/B

3.72

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

12.38

ROCE

Profit Growth

Listing Date

24-Nov-99

Promoter Holding

35.66%

FII Holding

1.59%

DII Holding

1.25%

Price Chart

Price Performance

1 Week0%

1 Month22%

3 Months48%

6 Months29%

1 Year29%

YTD29%

Moving Average

5 Day SMA51

10 Day SMA51

20 Day SMA48

30 Day SMA46

50 Day SMA45

61 Day SMA43

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	53	51	52	53
Resistance 2	52	50	51	52
Resistance 1	51	50	51	51
Pivot Point	50	50	50	50
Support 1	49	50	50	50
Support 2	49	50	49	49
Support 3	48	50	49	48

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Aug 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 35.66%	(0.01) 35.66%	(0.01) 35.66%	(0.01) 35.66%	(0.01) 35.66%	(0.01) 35.66%	(0.01) 35.66%	(-2.61) 35.66%	(0.01) 38.22%	(0.01) 38.22%	(0.01) 38.22%	(0.01) 38.22%	(0.01) 38.22%	(0.01) 38.22%	(0.01) 38.22%	(1.51) 38.22%	(-1.61) 36.74%	(3.81) 38.38%	(0.01) 34.54%
FIIs	(0.01) 1.59%	(0.01) 1.62%	(-0.11) 1.62%	(-0.21) 1.72%	(-0.31) 1.94%	(0.11) 2.22%	(-5.61) 2.08%	(6.11) 7.72%	(-0.21) 1.67%	(-0.31) 1.85%	(0.81) 2.11%	(0.31) 1.29%	(0.01) 1.00%	(0.11) 0.96%	(-0.31) 0.89%	(0.21) 1.15%	(0.01) 0.95%	(0.01) 0.96%	(0.01) 0.91%
DIIs	(0.01) 1.25%	(-0.21) 1.25%	(0.01) 1.49%	(-0.21) 1.50%	(0.01) 1.67%	(-0.11) 1.64%	(-1.21) 1.69%	(0.71) 2.84%	(0.01) 2.14%	(-0.11) 2.15%	(-0.11) 2.21%	(0.01) 2.27%	(-0.61) 2.32%	(-0.81) 2.93%	(-0.21) 3.74%	(-0.11) 3.98%	(3.01) 4.08%	(-0.11) 1.07%	(0.01) 1.16%
Government	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.00%	0.00%	0.00%
Public	61.50%	61.46%	61.22%	61.09%	60.72%	60.46%	60.57%	53.77%	57.96%	57.76%	57.46%	58.20%	58.45%	57.88%	57.15%	56.63%	58.24%	59.59%	63.39%
No. of Shareholders	447,286	453,137	461,853	461,180	468,860	448,361	430,929	352,839	348,766	336,019	304,289	304,001	301,832	306,150	306,030	290,367	287,115	261,437	255,155

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	485	484	412	425	466	453	438	455	423	445	422	401	364	348	403	302	368	396	395	387
Sales Growth % (YoY)	4%	6.9%	-6%	-6.6%	10.1%	1.8%	3.8%	13.5%	16.3%	27.6%	4.7%	32.6%	-1.2%	-12.1%	1.9%	-21.8%	28.5%	29%	17.5%	50.1%
Sales Growth % (QoQ)	0.2%	17.5%	-3.1%	-8.8%	2.9%	3.4%	-3.7%	7.6%	-4.9%	5.5%	5.2%	10.2%	4.6%	-13.6%	33.4%	-17.9%	-7.1%	0.3%	2.1%	-
Expenses	460	438	381	401	424	417	394	404	375	394	388	375	348	328	374	288	350	364	353	343
Operating Profit	24	46	31	24	42	36	44	52	48	51	34	26	16	21	29	15	19	32	42	44
OPM %	5	10	7	6	9	8	10	11	11	11	8	7	4	6	7	5	5	8	11	11
Other Income	8	4	30	4	5	5	5	3	4	4	3	2	3	1	1	1	3	3	3	2
Interest	4	4	4	4	5	1	1	1	1	2	0	0	1	1	0	0	1	1	-9	0
Depreciation	6	10	11	9	16	5	2	6	10	8	8	8	7	7	7	7	7	7	7	7
Profit before tax	23	35	46	16	26	35	46	48	42	44	29	21	11	14	22	8	14	27	47	39
Tax %	33	22	10	26	21	24	24	25	32	27	26	29	26	36	29	32	13	21	20	21
Net Profit	16	28	41	11	20	27	35	36	29	32	21	15	8	9	16	6	12	22	37	30
Net Profit Growth % (QoQ)	-42.9%	-31.7%	272.7%	-45%	-25.9%	-22.9%	-2.8%	24.1%	-9.4%	52.4%	40%	87.5%	-11.1%	-43.8%	166.7%	-50%	-45.5%	-40.5%	23.3%	-
Net Profit Growth % (YoY)	-20%	3.7%	17.1%	-69.4%	-31%	-15.6%	66.7%	140%	262.5%	255.6%	31.2%	150%	-33.3%	-59.1%	-56.8%	-80%	-	-	-	-
TTM Net Profit	96	100	99	93	118	127	132	118	97	76	53	48	39	43	56	77	101	89	67	0
EPS in Rs	0.29	0.5	0.75	0.2	0.37	0.49	0.64	0.71	0.55	0.63	0.42	0.29	0.16	0.18	0.31	0.11	0.26	0.48	0.83	0.68

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	1806	1812	1690	1418	1547	1188	853	769	607	595	485	401	367	326
Sales Growth %	-0.3%	7.2%	19.2%	-8.4%	30.2%	39.3%	11%	26.7%	1.8%	22.8%	21.1%	9.2%	12.6%	12.6%
Expenses	1680	1638	1532	1338	1410	1070	785	701	542	534	424	352	318	295
Operating Profit	126	174	159	80	137	119	69	68	65	61	62	48	49	31
OPM %	7	10	9	6	9	10	8	9	11	10	13	12	13	10
Other Income	47	18	14	6	10	12	9	4	4	4	-3	1	4	6
Interest	16	8	4	2	-7	2	2	2	4	8	10	9	10	12
Depreciation	36	29	33	28	28	30	37	40	34	34	35	39	46	46
Profit before tax	120	155	135	56	127	99	39	29	30	24	13	2	-3	-21
Tax %	20	24	29	31	20	1	14	1	0	0	-1	6	0	0
Net Profit	96	118	97	39	102	97	34	29	30	24	13	2	-3	-21
Net Profit Growth %	-18.6%	21.6%	148.7%	-61.8%	5.2%	185.3%	17.2%	-3.3%	25%	84.6%	550%	166.7%	85.7%	-
EPS in Rs	1.73	2.15	1.88	0.76	2.13	2.16	0.75	0.64	0.66	0.53	0.28	0.05	-0.06	-0.46
Dividend Payout %	12	9	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	32	73	-91	-60	51	11	17	63	41	50	51	34	34
Cash from Investing Activity	-322	-83	-47	-32	-70	-12	-13	-27	-14	-27	-32	-1	-3
Cash from Financing Activity	300	5	144	66	47	5	0	-38	-24	-27	-19	-29	-30
Net Cash Flow	10	-5	6	-26	28	4	4	-1	3	-4	0	4	1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	110	110	110	110	102	102	96	90	90	90	90	90	90	90	90	90
Reserves	1137	1087	1047	1001	745	651	483	335	194	163	136	106	91	78	88	90
Borrowings	208	158	105	33	29	25	19	17	133	132	134	169	187	201	209	231
Other Liabilities	482	381	517	418	417	332	473	416	246	230	226	173	156	121	103	95
Total Liabilities	1936	1736	1778	1562	1293	1110	1070	858	663	615	586	538	524	489	490	506
Fixed Assets	513	471	489	355	307	267	252	225	216	236	264	272	297	322	368	409
CWIP	22	26	28	18	24	17	14	2	0	0	0	0	0	0	0	0
Investments	124	136	85	132	1	0	0	1	1	0	0	0	0	0	0	4
Other Assets	1277	1104	1176	1056	960	827	804	631	446	379	321	266	227	167	121	93
Total Assets	1936	1736	1778	1562	1293	1110	1070	858	663	615	586	538	524	489	490	506

Delivery

Delivery Data: MOREPENLAB

#	Date	51 131% 119	Value (Cr)	Q/T 358	Del 29	Del 90
1	4-Sep	114	202	255	32	65
2	3-Sep	117	393	259	25	99
3	2-Sep	112	399	299	24	97
4	1-Sep	104	261	290	26	68
5	31-Aug	107	437	339	25	110
6	28-Aug	106	400	363	30	122
7	27-Aug	97	143	333	31	44
8	26-Aug	97	112	340	33	37
9	25-Aug	94	84	304	30	25
10	24-Aug	95	160	317	27	44
11	21-Aug	96	243	347	24	58
12	20-Aug	96	447	359	25	111
13	19-Aug	88	94	330	27	25
14	18-Aug	88	308	327	25	78
15	17-Aug	90	400	364	26	105
16	14-Aug	84	331	390	22	73
17	13-Aug	81	414	376	15	64
18	12-Aug	73	100	379	45	45
19	11-Aug	77	74	293	31	23
20	10-Aug	79	122	372	30	36
21	7-Aug	80	295	411	16	48
22	6-Aug	79	805	394	13	103
23	5-Aug	77	902	442	19	175
24	4-Aug	69	435	429	30	129
25	3-Aug	58	35	381	40	14
26	31-Jul	57	14	299	37	5
27	30-Jul	56	20	280	35	7
28	29-Jul	58	35	371	38	13
29	28-Jul	55	17	295	40	7
30	27-Jul	57	52	338	29	15
31	24-Jul	54	34	316	28	10
32	23-Jul	52	34	334	31	10
33	22-Jul	53	44	357	39	17
34	21-Jul	57	32	309	34	11
35	20-Jul	58	27	313	37	10
36	17-Jul	59	45	328	35	16
37	16-Jul	61	28	347	31	9
38	15-Jul	61	69	425	31	22
39	14-Jul	63	63	354	27	17
40	13-Jul	62	95	363	32	31
41	10-Jul	61	49	384	30	15
42	9-Jul	61	83	387	35	29
43	8-Jul	59	70	373	35	25
44	7-Jul	61	67	378	27	18
45	6-Jul	61	73	395	38	28
46	3-Jul	59	57	395	32	18
47	2-Jul	60	86	419	38	33
48	1-Jul	63	243	461	22	53
49	30-Jun	59	315	427	26	81
50	29-Jun	55	65	380	34	22

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	6,191c	210c	3.29
03-Sep	6,402c	522c	8.87
01-Sep	5,880c	103c	1.71
31-Aug	5,983c	703c	13.32
27-Aug	5,280c	69c	1.31
26-Aug	5,211c	60c	1.17
25-Aug	5,151c	38c	0.74
24-Aug	5,189c	44c	0.85
21-Aug	5,145c	301c	6.22
19-Aug	4,844c	36c	0.74
18-Aug	4,808c	101c	2.06
17-Aug	4,910c	300c	6.51
14-Aug	4,609c	228c	5.20
13-Aug	4,381c	357c	8.86
12-Aug	4,025c	333c	7.63
11-Aug	4,357c	40c	0.91
10-Aug	4,397c	33c	0.77
06-Aug	4,364c	1,221c	38.87
04-Aug	3,143c	26c	0.84
31-Jul	3,116c	26c	0.83
30-Jul	3,091c	0	0
29-Jul	3,091c	74c	2.45
28-Jul	3,017c	85c	2.74
27-Jul	3,101c	153c	5.20
24-Jul	2,948c	0	0

Stock Checklist

Price is above from 52 week high low average: 93%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 4 fund scheme(s) across 2 fund house(s) as of Aug26 · Total value ₹0 Cr · 2 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.14%	+0.03%	0.1
Motilal Oswal Mutual Fund	2	0.02%	-	0

Morepen Laboratories Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements